Trial updateRetina
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Recruiting. Phase 2. Registered enrolment: 324. ONL Therapeutics
Why it matters
Track this study through NCT06659445. No results are posted in this registry record.
The study at a glance
- Registry status
- Recruiting
- Phase
- Phase 2
- Registered enrolment
- 324
- Results posted
- No
- Sponsor
- ONL Therapeutics
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.
References (1)
Source date: 10 Sept 2026 · United States · Austria · Canada · Czechia · Germany · Greece · Hungary · Poland · Portugal · Spain · Switzerland · United Kingdom